Press Releases

GlobeNewswire, Inc.

VIENNA, Va., Sept. 09, 2026 (GLOBE NEWSWIRE) -- eHealth Exchange™, one of the nation’s oldest and largest health information networks, today announces its 2026 annual meeting agenda.

GlobeNewswire, Inc.

DRESDEN, Germany, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Lipotype introduced the Lipidomics Excellence Award (LEA) to give academic groups working on fundamental lipid biology free access to comprehensive lipid analysis.

EIN Presswire

Global Citizen Solutions published its 2026 Global Retirement Index, a comparative benchmark of 46 retirement or passive-income visa programs worldwide.

GlobeNewswire, Inc.

Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions.

EIN Presswire

Metbox, 11 years in remote metering, on what EU rules from 2027 mean for district heating and water operators, and where the sector goes next.

GlobeNewswire, Inc.

Vail, CO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- U.S. Ski & Snowboard has announced the promotion of Thomas R. Hackett, M.D., to Chief Medical Officer (CMO). Dr. Hackett, a complex knee and shoulder surgeon at The Steadman Clinic and sports medicine...

GlobeNewswire, Inc.

LAS VEGAS, NEVADA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, together with its...

GlobeNewswire, Inc.

In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up to 52 weeks, including prior placebo patients Denifanstat showed progressive and sustained improvements across all efficacy...

EIN Presswire

HANGZHOU, ZHEJIANG, CHINA, September 30, 2026 /⁨EINPresswire.com⁩/ -- Global buyers are increasingly seeking reliable sources for bathroom products amid rising demand for functional and stylish bathroom mirror solutions.

MENAFN

(MENAFN) Six European Union member states are calling for the bloc to reduce its next seven-year budget by several hundred billion euros, according to reports on Tuesday.

EIN Presswire

Freight forwarders can access a wider range of airline capacity, services, dynamic pricing and eBooking through ATC on CargoWise AirlineConnect (WTC:WiseTech Global) SYDNEY, NSW, AUSTRALIA, September 29, 2026 /⁨EINPresswire.com⁩/ -- WiseTech...

EIN Presswire

leagend brings 20+ years of automotive electronics expertise and new supercapacitor technology to Australia’s automotive aftermarket.

GlobeNewswire, Inc.

SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...

Office of Illinois Attorney General

Chicago – Attorney General Kwame Raoul announced a Vienna, Illinois man pleaded guilty to defrauding Johnson, Hardin and Pope counties out of over $100,000 while employed as the Johnson County 911 administrator.

EIN Presswire

VIENNA, AUSTRIA, August 20, 2026 /⁨EINPresswire.com⁩/ -- TAG Therapeutics a biotechnology company developing precision medicines for diseases driven by telomere dysfunction, today announces the publication of compelling preclinical data supporting...

EIN Presswire

California family business brings together affordable fashion, entrepreneurship, music and entertainment while creating opportunities for independent designers.

GlobeNewswire, Inc.

SAN CARLOS, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need,...

EIN Presswire

Destination-level research finds $178 billion in business traveler spending in 25 cities contributed $93B in local GDP, nearly $55B in tax revenue and 1.4M jobs ALEXANDRIA, VA, UNITED STATES, September 29, 2026 /⁨EINPresswire.com⁩/ -- From New...

GlobeNewswire, Inc.

The Phase I clinical trial will evaluate a proprietary drug candidate formulated using Cyprumed’s oral tablet technology, marking the first Cyprumed technology program to enter human clinical development The milestone triggers a payment to...

GlobeNewswire, Inc.

Positive interim data from Phase Ib proof-of-concept trial will be presented at the IPPF Scientific Symposium on Pemphigus and Pemphigoid and at EADV Congress 2026 Data positions nebaprubart as a potential therapy across a broad range of...